Trial Profile
An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 19 Jun 2017
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Expanded access; Therapeutic Use
- Sponsors Takeda Oncology
- 19 Jun 2017 New trial record